Table 1.
Baseline demographics, BNF factor, settings, and antipsychotics of participants.
| N = 272 | N (%), mean (standard deviation-SD), median (interquartile rang-IQR) | |
|---|---|---|
| Age in years, N (%) | 18 | 3 (1.1) |
| 19–39 | 151 (55.5) | |
| 40–69 | 114 (41.9) | |
| >=70 | 4 (1.5) | |
| Gender, N (%) | Male | 112 (41.2) |
| Female | 160 (58.8) | |
| Antipsychotic therapeutic class, N (%) | Atypical | 209 (76.8) |
| Typical | 63 (23.2) | |
| Number of medication, mean (SD) | 2.46 (1.73) | |
| Number of admission days, median (IQR) | 31.00 (27.00–––37.00) | |
| BNF factor, mean (SD) | 0.599 (0.551) | |
| BNF interpretation, N (%) | High | 19 (7.0) |
| Low | 253 (93.0) | |
| Setting, N (%) | Outpatient | 149 (54.8) |
| Inpatient | 123 (45.2) | |
| Aripiprazole, N (%) | 145 (53.3) | |
| Haloperidol, N (%) | 88 (32.4) | |
| Quetiapine, N (%) | 65 (23.9) | |
| Risperidone, N (%) | 64 (23.5) | |
| Olanzapine, N (%) | 58 (21.3) | |
| Amisulpride, N (%) | 22 (8.1) | |
| Clozapine, N (%) | 22 (8.1) | |
| Chloropromazine, N (%) | 9 (3.3) | |
| Paliperidonelnevga, N (%) | 8 (2.9) | |
| Zuclopenthixol, N (%) | 6 (2.2) | |
Bold: indicate higher percent.